Cambridge Investment Research Advisors, Inc. Vbi Vaccines Inc Transaction History

Cambridge Investment Research Advisors, Inc.

$29.9 Billion
Q4 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$0.29 - $0.64 $30,368 - $67,020	-104,720 Reduced 3.15%	3,222,101 $976,000
Q4 2022 Feb 08, 2023	BUY	$0.38 - $22.5 $73,824 - $4.37 Million	194,276 Added 6.2%	3,326,821 $1.3 Million
Q3 2022 Oct 17, 2022	BUY	$0.73 - $23.4 $656,558 - $21 Million	899,395 Added 40.27%	3,132,545 $0
Q2 2022 Jul 13, 2022	BUY	$0.66 - $1.81 $28,677 - $78,644	43,450 Added 1.98%	2,233,150 $1.81 Million
Q1 2022 May 12, 2022	BUY	$1.27 - $2.47 $54,853 - $106,684	43,192 Added 2.01%	2,189,700 $3.63 Million
Q4 2021 Feb 03, 2022	BUY	$2.21 - $3.22 $178,026 - $259,387	80,555 Added 3.9%	2,146,508 $5.02 Million
Q3 2021 Nov 02, 2021	BUY	$2.8 - $3.72 $339,304 - $450,789	121,180 Added 6.23%	2,065,953 $6.43 Million
Q2 2021 Aug 10, 2021	BUY	$2.61 - $4.17 $456,554 - $729,437	174,925 Added 9.88%	1,944,773 $6.51 Million
Q1 2021 May 07, 2021	BUY	$2.91 - $4.32 $363,220 - $539,213	124,818 Added 7.59%	1,769,848 $5.5 Million
Q4 2020 Feb 04, 2021	SELL	$2.15 - $3.5 $409,194 - $666,130	-190,323 Reduced 10.37%	1,645,030 $4.52 Million
Q3 2020 Oct 29, 2020	BUY	$2.77 - $6.17 $334,086 - $744,157	120,609 Added 7.03%	1,835,353 $5.25 Million
Q2 2020 Jul 27, 2020	BUY	$0.87 - $3.13 $4,482 - $16,125	5,152 Added 0.3%	1,714,744 $5.32 Million
Q1 2020 May 08, 2020	SELL	$0.73 - $1.91 $4,753 - $12,436	-6,511 Reduced 0.38%	1,709,592 $1.62 Million
Q4 2019 Feb 04, 2020	BUY	$0.48 - $1.38 $43,651 - $125,497	90,940 Added 5.6%	1,716,103 $2.37 Million
Q3 2019 Nov 06, 2019	BUY	$0.47 - $1.05 $88,178 - $196,994	187,614 Added 13.05%	1,625,163 $763,000
Q2 2019 Aug 15, 2019	BUY	$0.65 - $2.12 $60,404 - $197,011	92,930 Added 6.91%	1,437,549 $0
Q1 2019 May 08, 2019	SELL	$1.54 - $2.01 $742 - $968	-482 Reduced 0.04%	1,344,619 $0
Q4 2018 Feb 05, 2019	SELL	$1.22 - $2.41 $27,962 - $55,237	-22,920 Reduced 1.68%	1,345,101 $2.15 Million
Q3 2018 Nov 02, 2018	BUY	$1.75 - $2.93 $116,459 - $194,985	66,548 Added 5.11%	1,368,021 $0
Q2 2018 Aug 10, 2018	SELL	$2.75 - $3.85 $247,346 - $346,284	-89,944 Reduced 6.46%	1,301,473 $0
Q1 2018 May 09, 2018	SELL	$3.5 - $4.47 $108,787 - $138,936	-31,082 Reduced 2.19%	1,391,417 $0
Q4 2017 Feb 22, 2018	BUY	$3.29 - $5.03 $22,533 - $34,450	6,849 Added 0.48%	1,422,499 $0
Q3 2017 Nov 07, 2017	BUY	$3.15 - $4.01 $118,629 - $151,016	37,660 Added 2.73%	1,415,650 $5.45 Million
Q2 2017 Aug 08, 2017	BUY	N/A	1,377,990	1,377,990 $5.99 Million

Others Institutions Holding VBIV

# of Institutions

Shares Held

688K

Call Options Held

Put Options Held

Frontier Wealth Management LLC Kansas City, MO

602K
Shares

$12,036
0.01% of portfolio
ETF Managers Group, LLC Summit, NJ

85.7K
Shares

$1,714
0.0% of portfolio

View Full List

About VBI Vaccines Inc

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

More about VBIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account